The Impact of Frailty on Cardiopulmonary Resuscitation Adverse Outcomes in Patients Requiring Code Blue Activation

StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Study sites: 2 to 1
    • Eligibility criteria expanded, about 2 words
  2. Primary completion date: Jul 30, 2025 to Apr 30, 2026
    • Start date: Jun 30, 2025 to Dec 1, 2025
    • Study completion date: Aug 31, 2025 to May 30, 2026
    v6
  3. Start date: Mar 15, 2025 to Jun 30, 2025v5
  4. Primary completion date: Dec 31, 2024 to Jul 30, 2025
    • Start date: Dec 1, 2023 to Mar 15, 2025
    • Study completion date: Dec 31, 2024 to Aug 31, 2025
    v4
  5. Primary completion date: Oct 31, 2024 to Dec 31, 2024
    • Study completion date: Dec 30, 2024 to Dec 31, 2024
    v3
  6. Primary completion date: May 31, 2024 to Oct 31, 2024
    • Study completion date: Jun 30, 2024 to Dec 30, 2024
    v2
  7. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The aim of this study was to determine the independent association of frailty with cardiopulmonary resuscitation and predictive factors in patients triggering code blue response
Trial Details
NCT Number NCT06405581
Lead Sponsor Umraniye Education and Research Hospital
Conditions
(from sponsor)		 Cardiac Arrest, Frailty, Respiratory Arrest
Related terms Apnea, Frailty, Heart Arrest
Enrollment 2 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov